Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 2Carcinoma, Ovarian Epithelial 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Small Cell Lung Carcinoma 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1

Interventions

Cisplatin 3Taxes 2Psychiatric Rehabilitation 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Etoposide 2rubitecan 1pembrolizumab 1monalizumab 1marimastat 1etoposide phosphate 1durvalumab 1ceralasertib 1carfilzomib 1atezolizumab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Platinum Compounds 1PM 01183 1Nivolumab 1NK Cell Lectin-Like Receptor Subfamily C 1Mental Status and Dementia Tests 1Isotretinoin 1Irinotecan 1Ipilimumab 1Introns 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Small Cell Lung Carcinoma × rubitecan × Clear all
NCT00006082 2012-09-24

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
38 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡